Residence Time

Residence time is the reciprocal of the dissociation rate constant (k_off). It represents the average time a single ligand-receptor complex persists before dissociation.

• Formula: τ = 1 / k_off
• Units: Typically expressed in minutes or hours
• Example: A ligand with k_off = 0.001 s^-1 has a residence time of ~16.7 minutes
• Measurement: Determined via surface plasmon resonance (SPR), stopped-flow kinetics, or radioligand binding assays

The dissociation half-life (t_1/2 = ln(2)/k_off) is a related metric often reported alongside residence time.

Residence time and binding affinity (K_D) describe different thermodynamic and kinetic properties. Two drugs can have identical K_D values but vastly different residence times.

• K_D = k_off / k_on: A ratio reflecting equilibrium occupancy
• τ = 1 / k_off: A pure kinetic parameter independent of the association rate
• Clinical relevance: A slow-dissociating antagonist can maintain receptor blockade even after plasma drug concentration falls below the K_D
• Example: The antipsychotic haloperidol exhibits a long residence time at D2 dopamine receptors, contributing to sustained efficacy despite fluctuating plasma levels

Extended residence time arises from specific molecular interactions that create a high kinetic barrier to dissociation. Key structural features include:

• Buried binding pockets: Ligands sequestered deep within the protein core experience slower solvent exposure and escape
• Hydrophobic enclosure: Water-mediated hydrogen bond networks must reorganize during unbinding, imposing an energetic penalty
• Conformational trapping: Ligand binding stabilizes a protein conformation that must undergo a slow structural rearrangement before release
• Covalent or pseudo-irreversible binding: Formation of a permanent or slowly reversible covalent bond with a target residue (e.g., cysteine)
• Example: The kinase inhibitor lapatinib exhibits a slow off-rate due to its type II binding mode that traps the DFG-out conformation of EGFR

Optimizing residence time is a strategic objective in kinetics-based drug design. Long residence times confer several therapeutic advantages:

• Prolonged pharmacodynamic effect: Target engagement persists beyond plasma clearance, enabling less frequent dosing
• Selectivity enhancement: A slow off-rate can compensate for modest binding selectivity, as the drug remains bound to the desired target longer
• Rebinding phenomena: In confined cellular environments, a dissociated ligand may rapidly rebind to the same or nearby receptor before diffusing away
• Resilience to competition: A drug with a long residence time resists displacement by endogenous ligands or competing substrates
• Design strategies: Structure-kinetic relationship (SKR) studies guide medicinal chemistry efforts to introduce hydrophobic contacts and rigidify the bound conformation

Predicting residence time computationally remains challenging due to the need to model rare unbinding events on long timescales. Current approaches include:

• Enhanced sampling molecular dynamics: Techniques like metadynamics, steered MD, and τ-random acceleration MD apply biasing potentials to accelerate ligand egress and reconstruct the free energy landscape
• Milestoning and Markov state models: Partition the unbinding pathway into discrete states and estimate transition rates between them to compute the overall off-rate
• Machine learning models: Graph neural networks and 3D convolutional networks trained on experimental k_off data to predict residence time from protein-ligand complex structures
• DeepResiD: A deep learning framework specifically designed to predict ligand residence times using structural interaction fingerprints
• Limitations: Accurate prediction requires explicit solvent representation and extensive sampling, making high-throughput virtual screening for residence time computationally expensive

For covalent inhibitors, residence time takes on a distinct mechanistic meaning governed by a two-step process:

• Step 1: Non-covalent recognition (K_I) — the inhibitor binds reversibly to the target
• Step 2: Covalent bond formation (k_inact) — a nucleophilic residue attacks the electrophilic warhead
• Effective residence time: For irreversible inhibitors, the complex lifetime is determined by the target protein's own degradation and resynthesis rate (target turnover), not by chemical dissociation
• Reversible covalent inhibitors: Compounds like cyanoacrylamides form covalent bonds with finite lifetimes, where residence time depends on the reverse reaction rate (k_rev)
• Design considerations: Balancing warhead reactivity to achieve sufficient residence time without promiscuous off-target labeling